Cargando…

Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers

Variants in SMAD4 or BMPR1A cause juvenile polyposis syndrome, a rare autosomal dominant condition characterized by multiple gastrointestinal hamartomatous polyps. A phenotype of attenuated adenomatous polyposis without hamartomatous polyps is rare. METHODS: We describe a retrospective cohort of ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosner, Guy, Petel-Galil, Yael, Laish, Ido, Levi, Zohar, Kariv, Revital, Strul, Hana, Gilad, Ophir, Gluck, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624493/
https://www.ncbi.nlm.nih.gov/pubmed/36049049
http://dx.doi.org/10.14309/ctg.0000000000000527
_version_ 1784822245002051584
author Rosner, Guy
Petel-Galil, Yael
Laish, Ido
Levi, Zohar
Kariv, Revital
Strul, Hana
Gilad, Ophir
Gluck, Nathan
author_facet Rosner, Guy
Petel-Galil, Yael
Laish, Ido
Levi, Zohar
Kariv, Revital
Strul, Hana
Gilad, Ophir
Gluck, Nathan
author_sort Rosner, Guy
collection PubMed
description Variants in SMAD4 or BMPR1A cause juvenile polyposis syndrome, a rare autosomal dominant condition characterized by multiple gastrointestinal hamartomatous polyps. A phenotype of attenuated adenomatous polyposis without hamartomatous polyps is rare. METHODS: We describe a retrospective cohort of individuals with SMAD4 or BMPR1A heterozygous germline variants, having ≥10 cumulative colorectal adenomas and/or colorectal cancer without hamartomatous polyps. All individuals had multigene panel and duplication/deletion analysis to exclude other genetic syndromes. RESULTS: The study cohort included 8 individuals. The pathogenic potential of the variants was analyzed. Variants detected included 4 missense variants, 1 nonsense variant, 1 splice site variant, and 2 genomic deletions. Features of pathogenicity were present in most variants, and cosegregation of the variant with polyposis or colorectal cancer was obtained in 7 of the 8 families. Three of 8 individuals had colorectal cancer (age less than 50 years) in addition to the polyposis phenotype. Two individuals had extraintestinal neoplasms (pancreas and ampulla of Vater). DISCUSSION: The clinical phenotype of SMAD4 and BMPR1A variants may infrequently extend beyond the classical juvenile polyposis syndrome phenotype. Applying multigene panel analysis of hereditary cancer-related genes in individuals with unexplained polyposis can provide syndrome-based clinical surveillance for carriers and their family members.
format Online
Article
Text
id pubmed-9624493
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-96244932022-11-03 Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers Rosner, Guy Petel-Galil, Yael Laish, Ido Levi, Zohar Kariv, Revital Strul, Hana Gilad, Ophir Gluck, Nathan Clin Transl Gastroenterol Article Variants in SMAD4 or BMPR1A cause juvenile polyposis syndrome, a rare autosomal dominant condition characterized by multiple gastrointestinal hamartomatous polyps. A phenotype of attenuated adenomatous polyposis without hamartomatous polyps is rare. METHODS: We describe a retrospective cohort of individuals with SMAD4 or BMPR1A heterozygous germline variants, having ≥10 cumulative colorectal adenomas and/or colorectal cancer without hamartomatous polyps. All individuals had multigene panel and duplication/deletion analysis to exclude other genetic syndromes. RESULTS: The study cohort included 8 individuals. The pathogenic potential of the variants was analyzed. Variants detected included 4 missense variants, 1 nonsense variant, 1 splice site variant, and 2 genomic deletions. Features of pathogenicity were present in most variants, and cosegregation of the variant with polyposis or colorectal cancer was obtained in 7 of the 8 families. Three of 8 individuals had colorectal cancer (age less than 50 years) in addition to the polyposis phenotype. Two individuals had extraintestinal neoplasms (pancreas and ampulla of Vater). DISCUSSION: The clinical phenotype of SMAD4 and BMPR1A variants may infrequently extend beyond the classical juvenile polyposis syndrome phenotype. Applying multigene panel analysis of hereditary cancer-related genes in individuals with unexplained polyposis can provide syndrome-based clinical surveillance for carriers and their family members. Wolters Kluwer 2022-08-31 /pmc/articles/PMC9624493/ /pubmed/36049049 http://dx.doi.org/10.14309/ctg.0000000000000527 Text en © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Rosner, Guy
Petel-Galil, Yael
Laish, Ido
Levi, Zohar
Kariv, Revital
Strul, Hana
Gilad, Ophir
Gluck, Nathan
Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers
title Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers
title_full Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers
title_fullStr Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers
title_full_unstemmed Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers
title_short Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers
title_sort adenomatous polyposis phenotype in bmpr1a and smad4 variant carriers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624493/
https://www.ncbi.nlm.nih.gov/pubmed/36049049
http://dx.doi.org/10.14309/ctg.0000000000000527
work_keys_str_mv AT rosnerguy adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers
AT petelgalilyael adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers
AT laishido adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers
AT levizohar adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers
AT karivrevital adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers
AT strulhana adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers
AT giladophir adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers
AT glucknathan adenomatouspolyposisphenotypeinbmpr1aandsmad4variantcarriers